This late-stage clinical trial company focuses on preventing inflammation and acute organ injury. It is developing a platform of new drugs to prevent inflammation in the kidneys, liver and lungs...

To read the full story on AllPennyStocks.com, click here.

Arch Biopartners (TSXV:ARCH)
Historical Stock Chart
Von Dez 2024 bis Jan 2025 Click Here for more Arch Biopartners Charts.
Arch Biopartners (TSXV:ARCH)
Historical Stock Chart
Von Jan 2024 bis Jan 2025 Click Here for more Arch Biopartners Charts.